This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wednesday's ETF Winners & Losers

Updated from 11:45 a.m. EDT with new stock prices

Exchange-traded funds tracking crude oil were the best performers of Wednesday's session, as a bullish inventory report from the Energy Department sent oil prices above the $94-a-barrel level.

Earlier, the Energy Department said oil stocks unexpectedly dropped by 3.9 million barrels last week, compared with expectations of a slight advance. A day after crude dropped 3.4%, the December contract was up today at $94.53 a barrel.

The United States Oil (USO) ETF was rising $3.74, or 5.4%, to $73.28. The iPath S&P GSCI Crude Oil Index (OIL) added $2.70, or 5.2%, to $54.29. The Ultra Oil & Gas ProShares (DIG) was up $4.41, or 4%, to $113.50.

Bundled securities following Asian markets were also higher during the current session. Overnight, China's CSI 300 Index advanced 1.7%, and indices in India, South Korea and Japan also finished higher.

The iPath MSCI India Index (INP) was recently up $3.81, or 4.3%, to $91.81. The iShares MSCI South Korea Index (EWY) was higher by $2.60, or 3.6%, to $74.85. The SPDR S&P China (GXC) climbed $ 4.04, or 3.7%, to $113.20.

On the other hand, several of the HealthShares ETFs were losing ground after Germany-based GPC Biotech released disappointing results of a phase III clinical study for its prostate cancer treatment. Shares were off more than 58% overseas, while Spectrum Pharmaceuticals (SPPI), which licensed the treatment in 2002, dropped 8.5%.

The HealthShares Emerging Cancer (HHJ) shed 70 cents, or 3.4%, to $19.86. The HealthShares GI/Gender Health (HHU) was down 85 cents, or 3.4%, to $23.98. The HealthShares Cardiology (HRD) was off 19 cents, or 0.8%, to $23.61.

The Internet Infrastructure HOLDRs (IIH) was also losing ground after Deutsche Securities downgraded holding Akamai Technologies (AKAM) to hold from buy. The stock was recently down 1.4%, and the Internet Infrastructure HOLDRs was falling 3 cents, or 0.5%, to $5.75.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
GXC $66.90 0.25%
DIG $33.89 0.15%
OIL $8.17 -3.50%
EWY $47.46 1.30%
INP $63.79 1.03%

Markets

Chart of I:DJI
DOW 16,216.62 +158.27 0.99%
S&P 500 1,924.43 +10.58 0.55%
NASDAQ 4,672.8630 +36.7580 0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs